National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search  E-Mail This Search
Clinical Trial Questions?
Get Help:

1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Cancer Type/Condition:  Skin cancer, nonmelanomatous (squamous and basal cell)
Stage/Subtype:  basal cell carcinoma of the skin
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: H-2007-0252, PRMC_CO08303, NCT00994240
2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 01, NCT00663650
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2007.489/32, NCT00799188
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLDE225B2203, EudraCT 2008 005506-40, NCT00961896
5.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHORI-2007-016, UCSF-05862, R01-CA-109584, NCT00489086, 05862
6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903
7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 - 75
Sponsor: NCI
Protocol IDs: CHORI-2007-022, 05862, CHORI-H473-26042, NCT00783965
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4476g, NCT00833417
9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DUSA-CP0104, NCT00865878
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLDE225B2204, EudraCT 2009-013665-26, NCT01033019
11.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCI 101/06, NCT00993512
12.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 2008L03278, NCT01043016
13.

Phase: No phase specified
Type: Treatment
Status: Approved-not yet active
Age: 49 to 89
Sponsor: Other
Protocol IDs: WN07DE002, EudraCT No: 2007-001961-14, NCT00463359
14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: E.03.26007.1, NCT00515970
15.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE-9Z07-CC417, CASE 9Z07-CC417, NCT00663910
16.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P070158, NCT00699829
17.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 0559/07, NCT00803907
18.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0813, NCT01010334
19.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTPR-0002, NCT01016899
New Search

Having trouble with this form? Check the help page or contact an NCI information specialist through LiveHelp online text chat or by calling 1-800-4-CANCER.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov